Tocilizumab every 4 weeks vs placebo
Proportion of participants with relapse‐free survival at ≥ 12 months · adults aged over 50 years with giant cell arteritis
Tocilizumab every 4 weeks probably leads to higher proportion of participants with relapse‐free survival at ≥ 12 months compared with placebo (moderate certainty).
1 finding from 1 review
- RR 4.25 [1.21, 14.88]1 study · 30 participantsModerate